IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Orexigen Therapeutics Inc

CUSIP: 686164AB0 | 28 institutional holders

Quarters

Q4 2017Q3 2017Q2 2017Q1 2017Q4 2016
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q4 2017

BVF Inc10,000,000
0.0% of portfolio›$3.6K
Oconnor, A Distinct Business Unit of UBS Asset Management Americas (LLC)7,500,000
0.0% of portfolio›$2.8M
Telemetry Investments, L.L.C.2,500,000
0.1% of portfolio›$875
StyleTurnoverLocationFiled
BVF Inc
10,000,000$3.6K0.0%CoreMediumSan Francisco, CA2018-02-14
Oconnor, A Distinct Business Unit of UBS Asset Management Americas (LLC)
7,500,000$2.8M0.0%N/AN/AChicago, IL2019-02-19
Telemetry Investments, L.L.C.
2,500,000$8750.1%N/AN/ANew York, NY2018-02-14